アラバマ州におけるがん（全種類）の臨床試験
アラバマ州内の拠点で、がん（全種類）に関する36件の研究が参加者を募集しています。
アラバマ州内の都市
公式研究テキスト（英語）
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
- The Kirklin Clinic of UAB Hospital, Birmingham
- The University of Alabama at Birmingham, Birmingham
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT06989437A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- UAB Medicine - UAB Hospital, Birmingham
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT06901531Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
- Quetzal Site 16, Birmingham
被験者募集中第3相
18歳〜71歳 · 全性別 · 2026/09/23更新 · NCT07504458A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
- Birmingham Hematology and Oncology Associates d/b/a Alabama Oncology /ID# 280063, Birmingham
- Usa Mitchell Cancer Institute /ID# 280198, Mobile
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/23更新 · NCT07365241TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
- University of Alabama at Birmingham Comprehensive Cancer Center, Birmingham
被験者募集中第2相
12歳以上 · 全性別 · 2026/09/22更新 · NCT02693535Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
- University of Alabama Birmingham, Birmingham
被験者募集中第2/3相
全年齢 · 全性別 · 2026/09/18更新 · NCT03435796RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- UAB, Psychiatry and Behavioral Neurology, Birmingham
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07002034A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
- The University of Alabama at Birmingham ( Site 1005), Birmingham
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/10更新 · NCT06818643A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Clearview Cancer Institute, Huntsville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/08更新 · NCT06119581HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
- University of Alabama at Birmingham Cancer Center, Birmingham
被験者募集中第1相
36 Months – 22 Years · 全性別 · 2026/09/04更新 · NCT03911388Project: Every Child for Younger Patients With Cancer
- Children's Hospital of Alabama, Birmingham
- USA Health Strada Patient Care Center, Mobile
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
- Childrens Hospital of Alabama, Birmingham
被験者募集中第2相
1歳〜39歳 · 全性別 · 2026/08/07更新 · NCT05999994Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- University of Alabama at Birmingham Cancer Center, Birmingham
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/07更新 · NCT06580314Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 004, Birmingham
被験者募集中第2相
18歳以上 · 女性 · 2026/07/16更新 · NCT06906341A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
- Clearview Cancer Institute - Huntsville - Cci Drive /ID# 278621, Huntsville
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/10更新 · NCT07023289A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
- University of Alabama at Birmingham, Birmingham
被験者募集中第1相
18歳以上 · 全性別 · 2026/07/10更新 · NCT06997029A Decisional Intervention for Older Adults With Acute Myeloid Leukemia and Their Caregivers
- University of Alabama at Birmingham, Division of Hematology and Oncology, Birmingham
被験者募集中
60歳以上 · 全性別 · 2026/07/06更新 · NCT06697600A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
- GSK Investigational Site, Birmingham
被験者募集中第1相
18歳以上 · 全性別 · 2026/06/25更新 · NCT06431594Childhood Cancer Survivor Study
- University of Alabama at Birmingham/Children's of Alabama, Birmingham
被験者募集中観察研究健康なボランティア歓迎
全年齢 · 全性別 · 2026/06/17更新 · NCT01120353Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Birmingham VA Medical Center, Birmingham, AL, Birmingham
被験者募集中
18歳〜75歳 · 全性別 · 2026/06/17更新 · NCT05486572Multisite Implementation of COMPRENDO
- Children's of Alabama/University of Alabama at Birmingham, Birmingham
被験者募集中健康なボランティア歓迎
18歳以上 · 全性別 · 2026/06/03更新 · NCT06055296Leading Healthy Eating and Activity Promotion Program
- University of Alabama at Birmingham, Birmingham
被験者募集中健康なボランティア歓迎
18歳〜89歳 · 全性別 · 2026/05/19更新 · NCT06868524Video Inspired Discussions About Ethical Outcomes in Pediatrics
- Children's of Alabama at Birmingham, Birmingham
被験者募集中
全年齢 · 全性別 · 2026/05/14更新 · NCT06786104I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
- University of Alabama at Birmingham, Birmingham
被験者募集中第2相
18歳以上 · 全性別 · 2026/05/06更新 · NCT01042379Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
- University of Alabama at Birmingham, Birmingham
- University of South Alabama, Mobile
被験者募集中
18歳以上 · 全性別 · 2026/04/30更新 · NCT05297734Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
- University of Alabama at Birmingham, Birmingham
被験者募集中
18歳以上 · 全性別 · 2026/02/24更新 · NCT07281287TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
- Alabama Oncology, Birmingham
被験者募集中観察研究
18歳〜99歳 · 全性別 · 2026/02/24更新 · NCT06207032Legal Evaluation for Greater Access to Cancer Care (LEGAL-CARE)
- The Kirklin Clinic, Birmingham
被験者募集中
18歳以上 · 全性別 · 2026/02/06更新 · NCT07197515GEMINI-NSCLC: NSCLC Biomarker Study
- Alabama Oncology, Birmingham
被験者募集中観察研究
18歳以上 · 全性別 · 2026/02/05更新 · NCT05236114Caris Biorepository Research Protocol
- University of South Alabama, Mobile
被験者募集中観察研究健康なボランティア歓迎
18歳以上 · 全性別 · 2026/01/21更新 · NCT01499394SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Birmingham
- Massive Bio SYNERGY-AI site, Mobile
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
- XCancer Research Network/Dothan Hematology & Oncology, Dothan
被験者募集中第1/2相
18歳以上 · 全性別 · 2025/10/24更新 · NCT06228326BMT-CARE: Psychosocial Intervention for Transplant Caregivers
- University of Alabama at Brimingham, Birmingham
被験者募集中
18歳以上 · 全性別 · 2025/10/15更新 · NCT06472089Making Healthy Habits Stick
- University of Alabama at Birmingham, Birmingham
被験者募集中
19歳以上 · 女性 · 2025/10/01更新 · NCT06745180Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- University of South Alabama Mitchell Cancer Institute, Mobile
被験者募集中
18歳以上 · 全性別 · 2024/11/27更新 · NCT03860883Collection and Distribution of Biospecimens for Novel Research Uses
- iSpecimen, Huntsville
被験者募集中観察研究健康なボランティア歓迎
1 Month – 89 Years · 全性別 · 2022/11/09更新 · NCT03848962ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。